菜单
Suggests using prednisolone 3–5 mg/d orally once or twice daily as a glucocorticoid alternative in primary adrenal insufficiency. Consider this option when evaluating glucocorticoid therapy, particularly in patients with reduced medication compliance.
默认使用会先检查来源的 Prompt；你也可以切换为直接命令，或下载本地副本。
决定是否安装前，请先阅读 SKILL.md，以及 SkillsMP 当前展示的配套文件。
用 Codex 或 Claude 帮你安装 复制这段 Prompt，粘贴到 Codex、Claude 或其他助手里，让它检查 Skill 页面并帮你完成安装。
直接命令不会经过审查 Prompt；运行前请先检查来源。
npx skills add https://github.com/dromlakhani/MD2SKILL --skill enda-prednisolone-alternative-glucocorticoid命令会保持在同一行。复制前请横向滚动并检查完整内容。
想先保存到本地？可下载 SkillsMP 当前能够提供的文件。
基于 SOC 职业分类
正在显示 SKILL.md
| name | enda-prednisolone-alternative-glucocorticoid |
| description | Suggests using prednisolone 3–5 mg/d orally once or twice daily as a glucocorticoid alternative in primary adrenal insufficiency. Consider this option when evaluating glucocorticoid therapy, particularly in patients with reduced medication compliance. |
Confirm diagnosis of primary adrenal insufficiency via ACTH stimulation test; assess current glucocorticoid regimen and adherence; evaluate need for mineralocorticoid replacement; review for pregnancy or other special considerations. If PAI is confirmed and glucocorticoid replacement is indicated, proceed to assess compliance.
Is the patient non‑adherent or experiencing reduced compliance with multiple‑dose glucocorticoid therapy? If yes, proceed to consider prednisolone; if no, continue with standard hydrocortisone regimen.
Select prednisolone dose 3–5 mg/d; choose once daily for simplicity or twice daily for more stable levels based on patient preference and lifestyle.
Prescribe prednisolone 3–5 mg/d orally once or twice daily; ensure adequate fludrocortisone replacement if mineralocorticoid deficiency present; educate on adherence and stress dosing; schedule follow‑up in 4 weeks.
Prednisolone has reduced mineralocorticoid activity, so may require increased fludrocortisone; avoid in children (synthetic long‑acting glucocorticoids not recommended); do not use as sole glucocorticoid if mineralocorticoid replacement is inadequate; monitor for Cushingoid signs (weight gain, insomnia, edema); avoid dexamethasone due to higher Cushingoid risk.
A 45‑year‑old woman with PAI on hydrocortisone 20 mg BID reports frequent missed doses; switched to prednisolone 4 mg once daily with fludrocortisone 100 µg daily; adherence improved and symptoms stable at 4‑week follow‑up.
Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710
TODO: consider adding scripts/calc.py for the enda-prednisolone-alternative-glucocorticoid calculator